The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes

被引：0
|
作者：
Malik, Raleigh E.
Mody, Reema
Lage, Maureen J.
Boye, Kristina
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-938-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
938-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Relationship Between Timing of Initiation on a Glucagon-like Peptide-1 Receptor Agonist and Glycosylated Hemoglobin Values Among Patients With Type 2 Diabetes
    Boye, Kristina S.
    Mody, Reema
    Lage, Maureen J.
    Malik, Raleigh E.
    CLINICAL THERAPEUTICS, 2020, 42 (09) : 1812 - +
  • [2] Glucagon-like Peptide-1 Receptor Agonist Use in Patients With Liver Cirrhosis and Type 2 Diabetes
    Yen, Fu-Shun
    Hou, Ming-Chih
    Wei, James Cheng-Chung
    Shih, Ying-Hsiu
    Hsu, Chung Y.
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (06) : 1255 - 1264
  • [3] Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes
    Rizzo, Manfredi
    Rizvi, Ali A.
    Sesti, Giorgio
    DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 613 - 614
  • [4] Initiating a Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes Mellitus
    Gavin, James R., III
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2012, 112 (01): : S16 - S21
  • [5] Glucagon-like peptide-1 receptor agonist prescribing patterns in adolescents with type 2 diabetes
    Bensignor, Megan O.
    Wolf, Jack M.
    Rudser, Kyle D.
    Kelly, Aaron S.
    Arslanian, Silva
    DIABETES OBESITY & METABOLISM, 2022, 24 (07): : 1380 - 1384
  • [6] Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study
    Peng, Xuejun Victor
    Ayyagari, Rajeev
    Lubwama, Robert
    Shi, Lizheng
    Price-Haywood, Eboni G.
    Hollander, Priscilla
    Fonseca, Vivian
    DIABETES THERAPY, 2020, 11 (04) : 995 - 1005
  • [7] Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study
    Xuejun Victor Peng
    Rajeev Ayyagari
    Robert Lubwama
    Lizheng Shi
    Eboni G. Price-Haywood
    Priscilla Hollander
    Vivian Fonseca
    Diabetes Therapy, 2020, 11 : 995 - 1005
  • [8] Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes
    Kuhadiya, Nitesh D.
    Prohaska, Ben
    Ghanim, Husam
    Dandona, Paresh
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 1054 - 1057
  • [9] Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries
    Divino, Victoria
    DeKoven, Mitch
    Hallinan, Shawn
    Varol, Nebibe
    Wirta, Sara Bruce
    Lee, Won Chan
    Reaney, Matthew
    DIABETES THERAPY, 2014, 5 (02) : 499 - 520
  • [10] Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries
    Victoria Divino
    Mitch DeKoven
    Shawn Hallinan
    Nebibe Varol
    Sara Bruce Wirta
    Won Chan Lee
    Matthew Reaney
    Diabetes Therapy, 2014, 5 : 499 - 520
12345